PortfoliosLab logo
Peijia Medical Ltd (9996.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG6981F1090

Highlights

Market Cap

HK$3.63B

Year Range

HK$2.16 - HK$5.88

Target Price

HK$6.49

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Peijia Medical Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2025FebruaryMarchAprilMay
-77.52%
98.35%
9996.HK (Peijia Medical Ltd)
Benchmark (^GSPC)

Returns By Period

Peijia Medical Ltd (9996.HK) returned 45.73% year-to-date (YTD) and 58.47% over the past 12 months.


9996.HK

YTD

45.73%

1M

31.22%

6M

47.21%

1Y

58.47%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of 9996.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-9.05%10.77%24.44%6.41%9.23%45.73%
2024-39.38%13.39%-27.95%0.00%0.00%-37.70%2.19%17.60%33.58%6.01%-2.84%5.57%-46.14%
202330.75%-8.96%-13.62%0.71%-31.11%-9.68%42.86%-17.50%-3.86%6.02%8.24%-7.74%-22.70%
2022-16.84%11.21%-42.28%-4.37%0.15%14.12%-21.01%2.45%-1.59%5.18%18.92%23.67%-28.12%
2021-9.57%-6.67%3.99%15.15%1.58%24.87%-15.77%-24.96%-10.72%-6.86%-11.68%-20.74%-52.84%
2020-1.74%38.46%-13.11%-15.41%4.65%-7.04%-17.93%36.89%9.30%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 80, 9996.HK is among the top 20% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 9996.HK is 8080
Overall Rank
The Sharpe Ratio Rank of 9996.HK is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of 9996.HK is 7979
Sortino Ratio Rank
The Omega Ratio Rank of 9996.HK is 8080
Omega Ratio Rank
The Calmar Ratio Rank of 9996.HK is 7777
Calmar Ratio Rank
The Martin Ratio Rank of 9996.HK is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Peijia Medical Ltd (9996.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current Peijia Medical Ltd Sharpe ratio is 0.93. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Peijia Medical Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
0.93
0.45
9996.HK (Peijia Medical Ltd)
Benchmark (^GSPC)

Dividends

Dividend History


Peijia Medical Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-84.49%
-7.86%
9996.HK (Peijia Medical Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Peijia Medical Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Peijia Medical Ltd was 93.98%, occurring on Jul 9, 2024. The portfolio has not yet recovered.

The current Peijia Medical Ltd drawdown is 84.49%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.98%Jun 29, 2021745Jul 9, 2024
-43.3%Jun 30, 2020102Nov 25, 2020142Jun 24, 2021244
-14.33%May 21, 20206May 28, 202011Jun 12, 202017
-2.9%May 19, 20201May 19, 20201May 20, 20202
-1.42%Jun 19, 20201Jun 19, 20203Jun 24, 20204

Volatility

Volatility Chart

The current Peijia Medical Ltd volatility is 21.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%December2025FebruaryMarchAprilMay
21.49%
11.11%
9996.HK (Peijia Medical Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Peijia Medical Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Peijia Medical Ltd is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for 9996.HK relative to other companies in the Medical Devices industry. Currently, 9996.HK has a P/S ratio of 5.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for 9996.HK in comparison with other companies in the Medical Devices industry. Currently, 9996.HK has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items